JPMorgan Chase & Co. Has $251,000 Holdings in Nano-X Imaging Ltd. (NASDAQ:NNOX)

JPMorgan Chase & Co. lifted its stake in shares of Nano-X Imaging Ltd. (NASDAQ:NNOX) by 16.7% in the 3rd quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 41,364 shares of the company’s stock after buying an additional 5,930 shares during the quarter. JPMorgan Chase & Co. owned about 0.07% of Nano-X Imaging worth $251,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds also recently modified their holdings of the company. Barclays PLC grew its holdings in Nano-X Imaging by 258.5% in the third quarter. Barclays PLC now owns 86,181 shares of the company’s stock worth $523,000 after purchasing an additional 62,140 shares during the period. State Street Corp grew its stake in shares of Nano-X Imaging by 2.1% in the 3rd quarter. State Street Corp now owns 983,305 shares of the company’s stock valued at $5,978,000 after buying an additional 20,279 shares during the period. The Manufacturers Life Insurance Company increased its position in Nano-X Imaging by 14.8% in the 2nd quarter. The Manufacturers Life Insurance Company now owns 20,210 shares of the company’s stock valued at $148,000 after buying an additional 2,600 shares in the last quarter. Verition Fund Management LLC bought a new stake in Nano-X Imaging in the 3rd quarter valued at about $88,000. Finally, Creative Planning acquired a new position in Nano-X Imaging during the 3rd quarter worth approximately $107,000. Institutional investors own 21.49% of the company’s stock.

Nano-X Imaging Stock Performance

Shares of NASDAQ NNOX opened at $7.28 on Friday. The stock has a market cap of $420.64 million, a price-to-earnings ratio of -8.56 and a beta of 1.97. Nano-X Imaging Ltd. has a fifty-two week low of $5.26 and a fifty-two week high of $14.28. The firm’s 50-day simple moving average is $7.56 and its 200 day simple moving average is $6.94.

Nano-X Imaging (NASDAQ:NNOX) last posted its earnings results on Thursday, November 21st. The company reported ($0.23) earnings per share for the quarter. Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. During the same period in the prior year, the business posted ($0.37) earnings per share. On average, sell-side analysts predict that Nano-X Imaging Ltd. will post -0.92 EPS for the current year.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on NNOX shares. Cantor Fitzgerald raised their price objective on Nano-X Imaging from $11.00 to $12.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. D. Boral Capital initiated coverage on shares of Nano-X Imaging in a research note on Monday, January 6th. They set a “buy” rating and a $23.00 price target for the company.

Nano-X Imaging Profile

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.